- Home
- GSHD vs FOLD Comparison
GSHD vs FOLD Comparison
Compare GSHD & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSHD
- FOLD
- Stock Information
- Founded
- GSHD 2003
- FOLD 2002
- Country
- GSHD United States
- FOLD United States
- Employees
- GSHD N/A
- FOLD N/A
- Industry
- GSHD Specialty Insurers
- FOLD Biotechnology: Pharmaceutical Preparations
- Sector
- GSHD Finance
- FOLD Health Care
- Exchange
- GSHD Nasdaq
- FOLD Nasdaq
- Market Cap
- GSHD 2.5B
- FOLD 2.9B
- IPO Year
- GSHD 2018
- FOLD 2007
- Fundamental
- Price
- GSHD $96.97
- FOLD $6.12
- Analyst Decision
- GSHD Buy
- FOLD Buy
- Analyst Count
- GSHD 10
- FOLD 10
- Target Price
- GSHD $115.40
- FOLD $16.22
- AVG Volume (30 Days)
- GSHD 265.8K
- FOLD 5.5M
- Earning Date
- GSHD 07-23-2025
- FOLD 08-07-2025
- Dividend Yield
- GSHD 6.13%
- FOLD N/A
- EPS Growth
- GSHD 129.07
- FOLD N/A
- EPS
- GSHD 1.26
- FOLD N/A
- Revenue
- GSHD $324,757,000.00
- FOLD $543,141,000.00
- Revenue This Year
- GSHD $18.40
- FOLD $19.84
- Revenue Next Year
- GSHD $24.82
- FOLD $23.18
- P/E Ratio
- GSHD $76.55
- FOLD N/A
- Revenue Growth
- GSHD 21.87
- FOLD 28.25
- 52 Week Low
- GSHD $57.80
- FOLD $5.51
- 52 Week High
- GSHD $130.39
- FOLD $12.65
- Technical
- Relative Strength Index (RSI)
- GSHD 38.92
- FOLD 51.42
- Support Level
- GSHD $98.51
- FOLD $5.66
- Resistance Level
- GSHD $105.01
- FOLD $6.45
- Average True Range (ATR)
- GSHD 3.70
- FOLD 0.21
- MACD
- GSHD -0.31
- FOLD 0.07
- Stochastic Oscillator
- GSHD 3.21
- FOLD 64.89
About GSHD Goosehead Insurance Inc.
Goosehead Insurance Inc operates as an insurance agency. Its insurance products consist of homeowner's insurance; auto insurance; other personal lines products including flood, wind and earthquake insurance; excess liability or umbrella insurance; specialty lines insurance (motorcycle, recreational vehicle and other insurance); commercial lines insurance (general liability, property, and auto insurance for small businesses); and life insurance. Geographically, it operates in Texas, California, Illinois, Florida, and other regions.
About FOLD Amicus Therapeutics Inc.
Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.